Beck Bode’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
Other funds holding ALXN
BBA
Beck Bode's ALXN Position: Q4 2020 in Review
Beck Bode sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 636 shares — an estimated $73K sold.
Beck Bode first reported a position in ALXN in Q4 2018 and held it in 7 quarters. The position peaked at $3.12M in Q2 2019. 827 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.
- Beck Bode reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Beck Bode sold 636 Alexion Pharmaceuticals shares in Q4 2020, an estimated $73K.
- Beck Bode first reported a position in Alexion Pharmaceuticals in Q4 2018 and held it in 7 quarters.
- Beck Bode's Alexion Pharmaceuticals position peaked at $3.12M in Q2 2019.
- 827 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.
Based on Beck Bode's 13F filing for Q4 2020.